Close Menu

SAN FRANCISCO - The 38th annual JP Morgan Healthcare Conference kicked off on Monday with several life science tools, molecular diagnostics, pharmaceutical, and biotech companies presenting before thousands of investors. Below are brief reports on the presentations covered by our team at the conference and in our offices in New York.


Agios Pharmaceuticals

Ivosidenib (Agios' Tibsovo) is expected to rake in $105 to $110 million in revenue by year end, said Agios CEO Jackie Fouse. 

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.

Jan
28

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.